Curaizon aims to change healthcare and improve drug-adherence through big data analytics delivered via the blockchain.
CuraServe is a healthcare ecosystem that aims to improve drug adherence and bring benefits to patients and healthcare providers. Curaizon uses a series of outreach tools and messages, supported by predictive modeling and behavioral analytics, to increase the rate of drug adherence. As the CuraServe solution helps patients, it’s also generating patient data. That data is then anonymized and made available through CuraData. The only way that pharmaceutical companies, academics and researchers can access this data by purchasing CuraTokens.
The CuraServe™ solution generates the information that drives the value of the CuraData™ platform. Curazon's data is the insight into real-time patient behaviour and adherence. Through the company's collaborations with research institutions, national health services and biotech companies, Curazon aims to create a valuable data source in healthcare.
|Pre-sale start date||01 Jun 2018|
|Pre-sale end date||08 Jun 2018|
|ICO start date||08 Jun 2018|
|ICO end date||31 Oct 2018|
|ICO token supply||250,000,000|
|Hard cap size||25,000,000 USD (fiat)|
|Country Limitations||China, Singapore, United States|
|Registration Country||United Kingdom|
|Additional Token Emission||No|
Week 1: 20% bonus
Week 2: 15% bonus
Week 3: 10% bonus
Week 4: 5% bonus
50% - Sale
15% - Partner &Project
20% - Reward program, bounty & advisors
15% - Team
50% - Technology Development
15% - Marketng
10% - Operatons
20% - Business Development
5% - Administraton
|Chief Data Officer||
Rating and Analytics
Click vote if you want this project to be Post-ICO Rated.
The vote has been noted.